Fresenius Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf
January 21 2020 - 9:24AM
Dow Jones News
By Kim Richters
Fresenius SE & Co. (FRE.XE) said Tuesday that its subsidiary
Fresenius Kabi has formed a joint venture with pharma peers
Bio-Techne Corp. (TECH) and Wilson Wolf.
The collaboration will focus on providing technology to develop
and commercialize cell and gene therapies, German health-care
company Fresenius said of its medicines division's venture.
The company didn't disclose any financial details of the joint
venture, which is equally owned by the three parties.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
January 21, 2020 09:09 ET (14:09 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Apr 2023 to Apr 2024